Status:
COMPLETED
Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial
Lead Sponsor:
Gabinete Berthier y Martínez
Collaborating Sponsors:
Pfizer
Conditions:
Stroke
Aphasia
Eligibility:
All Genders
18-69 years
Phase:
PHASE4
Brief Summary
* Aphasia (impairment of language function due to brain damage)may be treated with speech-language therapy and drugs. Several drugs have been studied but with limited success. * Recent data suggest th...
Detailed Description
* Prior clinical information of donepezil treatment of post-stroke aphasia comes from single-case studies, small case-series and an open-label study. In addition, an extension phase of a small open-la...
Eligibility Criteria
Inclusion
- Chronic aphasia of more than one year duration. Must be able to complete protocol.
Exclusion
- Heart block
- Bronchial Asthma
- Hypersensitivity to donepezil
- Dementia
- Major psychiatric illness
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00196690
Start Date
February 1 2003
End Date
March 1 2005
Last Update
September 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gabinete Berthier y Martínez, Malaga, Spain. Centro de Investigaciones Médico-Sanitarias (CIMES), UNiversity of Malaga, Malaga, Spain.
Málaga, Malaga, Spain, 29001